Science Corner with David Friedberg: GLP-1 Study Shows Encouraging Results
- Feb 10, 2025
- 12:17
- Full Episode
Full episode: https://youtu.be/R3q5TrwSek0
Link to study: https://www.nature.com/articles/s41591-024-03412-w
Follow the besties: https://x.com/chamath https://x.com/Jason https://x.com/DavidSacks https://x.com/friedberg
Follow on X: https://x.com/theallinpod
Follow on Instagram: https://www.instagram.com/theallinpod
Follow on TikTok: https://www.tiktok.com/@theallinpod
Follow on LinkedIn: https://www.linkedin.com/company/allinpod
Intro Music Credit: https://rb.gy/tppkzl https://x.com/yung_spielburg
Intro Video Credit: https://x.com/TheZachEffect
Brief Summary
A study on GLP-1 drugs reveals significant health benefits for diabetes patients beyond weight loss.
Key points
- The Power of VA Data. Researchers utilized VA data to link Epstein-Barr virus to multiple sclerosis.
- GLP-1 Drug Benefits. GLP-1 drugs show significant health benefits beyond weight loss, including reduced cardiac arrest risk.
- Cautious Approach to GLP-1. A discussion on the importance of measuring effects before starting GLP-1 drugs.
Episode highlights
- The Power of VA DataResearchers utilized VA data to link Epstein-Barr virus to multiple sclerosis.“No one got MS that didn't get Epstein-Barr virus.”0:36Feb 10, 2025
- GLP-1 Drug BenefitsGLP-1 drugs show significant health benefits beyond weight loss, including reduced cardiac arrest risk.“A 30% decrease in the probability of having cardiac arrest.”2:28Feb 10, 2025
- Cautious Approach to GLP-1A discussion on the importance of measuring effects before starting GLP-1 drugs.“I want to measure the effects first.”6:06Feb 10, 2025
Tension
45/ 100Some tension
